Gene · 2053
Papers2,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Upregulated Nuclear Expression of Soluble Epoxide Hydrolase Predicts Poor Outcome in Breast Cancer Patients: Importance of the Digital Pathology Approach. | Int J Mol Sci | 2024 | 39125591 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism regulates the development of retinopathy of prematurity among preterm infants. | J Neurochem | 2024 | 39073120 | PubTator, text mining | PubMed |
| Exploring serial crystallography for drug discovery. | IUCrJ | 2024 | 39072424 | PubTator, text mining | PubMed |
| Exploring the Antiangiogenic and Anti-Inflammatory Potential of Homoisoflavonoids: Target Identification Using Biotin Probes. | Biomolecules | 2024 | 39062499 | PubTator, text mining | PubMed |
| Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes. | J Diabetes Complications | 2024 | 39059187 | PubTator, text mining | PubMed |
| Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma. | PLoS One | 2024 | 39052598 | PubTator, text mining | PubMed |
| Residual effect of sequential 4-channel neuromuscular electrical stimulation evaluated by high-resolution manometry. | Biomed Eng Online | 2024 | 39049019 | PubTator, text mining | PubMed |
| Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models. | Int J Mol Sci | 2024 | 39000229 | PubTator, text mining | PubMed |
| Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors. | Molecules | 2024 | 38998987 | PubTator, text mining | PubMed |
| Genomic analysis and identification of a novel superantigen, SargEY, in Staphylococcus argenteus isolated from atopic dermatitis lesions. | mSphere | 2024 | 38990001 | PubTator, text mining | PubMed |
| scPLAN: a hierarchical computational framework for single transcriptomics data annotation, integration and cell-type label refinement. | Brief Bioinform | 2024 | 38935069 | PubTator, text mining | PubMed |
| Quinolinyl-based multitarget-directed ligands with soluble epoxide hydrolase and fatty acid amide hydrolase inhibitory activities: Synthetic studies and pharmacological evaluations. | Heliyon | 2024 | 38912512 | PubTator, text mining | PubMed |
| Inhibition of the STAT3-EPHX2 axis promotes regression of ulcerative colitis by treatment with novel porphyrin derivative. | Bioorg Chem | 2024 | 38908128 | PubTator, text mining | PubMed |
| Inhibition of soluble epoxide hydrolase by natural isothiocyanates. | Biochem Biophys Res Commun | 2024 | 38897040 | PubTator, text mining | PubMed |
| Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice. | FASEB J | 2024 | 38786655 | PubTator, text mining | PubMed |
| Repositioning of Small Molecules through the Inverse Virtual Screening in silico Tool: Case of Benzothiazole-Based Inhibitors of Soluble Epoxide Hydrolase (sEH). | Chempluschem | 2024 | 38753468 | PubTator, text mining | PubMed |
| PharmaCore: The Automatic Generation of 3D Structure-Based Pharmacophore Models from Protein/Ligand Complexes. | J Chem Inf Model | 2024 | 38728062 | PubTator, text mining | PubMed |
| Overexpression of soluble epoxide hydrolase reduces post-ischemic recovery of cardiac contractile function. | Biochem Pharmacol | 2024 | 38679211 | PubTator, text mining | PubMed |
| Multi-tissue profiling of oxylipins reveal a conserved up-regulation of epoxide:diol ratio that associates with white adipose tissue inflammation and liver steatosis in obesity. | EBioMedicine | 2024 | 38677183 | PubTator, text mining | PubMed |
| The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids. | Front Pharmacol | 2024 | 38628644 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2053/papers?page=10